<DOC>
	<DOCNO>NCT01625169</DOCNO>
	<brief_summary>HIV positive pregnant woman receive potent combination antiretroviral therapy least last trim pregnancy , proper obstetric intervention able avoid breast feeding , decrease risk infect infant 1 % . Breast milk HIV-1 RNA ( cell free ) viral load significantly associate breast milk transmission , 2-fold increase risk transmission associate every 10-fold increase breast milk viral load report . In addition , cell associate virus ( HIV DNA ) associate significant increase risk transmission independent level cell-free viral RNA . However , multiple study HIV positive woman give birth show exclusive breast-feeding carry much low risk HIV transmission mix breast-feeding ( define breast milk along complementary food , milk , and/or infant formula ) . The propose study measure antiretroviral ( ARV ) drug etravirine concentration blood breast milk postpartum HIV positive woman HAART therapy . The short-term goal determine much etravirine penetrate breast milk , whether lead undetectable HIV viral load breast milk therefore potential decrease risk transmission HIV breast milk . The long term goal see breast milk HIV level lower sufficiently prevent maternal child transmission ( MTCT ) HIV infant receive breast feed resource poor area .</brief_summary>
	<brief_title>Etravirine Pharmacokinetics HIV Viral Load Breast Milk Plasma</brief_title>
	<detailed_description />
	<mesh_term>Etravirine</mesh_term>
	<criteria>1 . HIV+ pregnant woman HAART prevention MTCT w/ undetectable viral load time delivery ( w/i 30 day delivery ) . 2 . 18 year old 3 . Only woman deem physician capable understand HIV positive woman breastfeed approach . 4 . Life expectancy great 6 month 5 . No known allergy etravirine 6 . Willingness subject adhere protocol requirement . 1 . Pregnant woman medical psychological contraindication breast milk expression . 2 . Requirements prohibit medication : ARV : Tipranavir/ritonavir , fosamprenavir/ritonavir , atazanavir/ritonavir , protease inhibitor administer without ritonavir , nonnucleoside reverse transcriptase inhibitor ( NNRTIs ) . Alternative/CAM : St. John 's wort Anticonvulsants : Phenobarbital , carbamazepine , phenytoin Antiinfectives : Rifampin</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>HIV</keyword>
	<keyword>Breast milk</keyword>
</DOC>